# The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19

> **NCT05371288** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of California, Irvine**

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** NAC (N-acetyl cysteine), Alpha lipoic acid (ALA), liposomal glutathione (GSH)

## Key facts

- **NCT ID:** NCT05371288
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-06
- **Primary completion:** 2025-09
- **Final completion:** 2025-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No longer studying long COVID
- **Last updated:** 2024-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05371288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05371288, "The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05371288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*